| |
|
|
|
CfPA - The Center for Professional Advancement, New Brunswick, NJ
February 16-17, 2012
Who Should Attend
This intensive course is intended for Professional individuals who work in the following areas:
• Topically applied product development in Pharmaceutical,
Cosmetics and Personal Care
• Dermatology community and related industries
• Marketing and sales who are interested in learning a novel
method for claim substantiation
• Formulation chemists Description
The Human Genome Project (HGP), completed in 2003, was a 13-year project coordinated by the U.S National Institute of Health that identified the gene sequences of all of the approximately 20,000-25,000 human genes. The project provided sequences for over 3 billion chemical base pairs that comprise the human genome.
However, gene sequence is only a piece of the puzzle. Gene expression, how the genes are regulated (i.e. turned on or off), plays an integral role in translating the DNA code to biological characteristics, in health and in disease. Ongoing research is being carried out in all areas of health to better understand gene expression in response to specific conditions.
Over the past decade, great progress has been made in developing high throughput techniques to measure gene expression. Starting as high cost complicated lab procedures not too long ago, gene expression analysis is now an affordable and relatively standard procedure utilized in most academic and commercial laboratories. Gene expression methods are generating new information regarding the specific mechanisms that underlie complex biological processes and physiological conditions.
This 2 day accredited introductory course is tailored towards the use of gene expression studies and their utilization in the development of skin care products, both in the Pharmaceutical and Personal Care industries. In addition to a thorough description of the methodologies, applications for efficacy and safety endpoints will be discussed.
|
|
|
|
|
|
|
|
Organized by:
|
|
CfPA - The Center for Professional Advancement |
|
|
Invited Speakers:
|
|
Nava Dayan, Ph.D.; Skin Care Research Expert
Dr. Dayan earned her Ph.D. in Pharmaceutics from the Hebrew University in Jerusalem specializing in skin delivery. She is currently an Associate Adjunct Professor in the Ernest Mario School of Pharmacy at Rutgers University, and the Research and Development and Safety Assessment Director at Lipo Chemicals Inc. During her 24 years of experience she has specialized in a variety of areas related to skin treatment.
Dr. Dayan has received numerous awards of excellence for various papers she has authored. She is the author and coauthor more then 150 publications including book chapters and was granted 8 patents. She is also the editor of the “Skin Aging Hand Book” published by Elsevier; “Innate Immunity of Skin and Oral Mucosa” Book co-edited with Prof. Philip Wertz, “Formulating Skin Care with Natural Products” Book coedited with Dr. Lambros Kromidas; both published by Wiley and sons. Dr. Dayan is a member of the Dermatopharmaceutics Focus Group, and the Abstract Review Committee for the American Association of Pharmaceutical Scientists (AAPS). She is serves as the Educational Chair of the NYSCC Chapter and on the Scientific Advisory Board of Health Beauty America Expo and the Center for Dermal Research at the Center for Biomaterials. Dr. Dayan teaches at Rutgers University and is the Director of a variety of courses at the Center for Professional Advancement.
Anna Jelaso Langerveld, Ph.D.; President and CEO, Genemarkers LLC
Dr. Langerveld has more than ten years of experience with state-of-the-art genomics methods. The former director of the Western Michigan University Environmental Institute Genomics Facility (2000-2005), Dr. Langerveld played an instrumental role in carrying out Affymetrix and Taqman qRT-PCR analyses for neurobiological, environmental and animal health applications. Dr. Langerveld founded Genemarkers LLC in 2007 and conducts contract-based genomics research for a myriad of clients, ranging from small organic skin care companies and university researchers to large companies, such as Pfizer and NuSkin. Her gene expression work has been published in numerous peer-reviewed journals, cited in the Wall Street Journal , and featured in Cosmetics & Toiletries (May, 2009) and GCI (June, 2010). Dr. Langerveld received her BA from SUNY Binghamton and her Ph.D. from the Interdisciplinary Program in Neurosciences at Tulane University (1998).
|
|
|
|
|
|
|
|
Deadline for Abstracts:
|
|
n/a
|
|
|
|
|
|
|
|
Registration:
|
|
Please click here for registration information.
|
|
|
E-mail:
|
|
sberg@cfpa.com
|
|
|
|
|
|
|
|
|